Global clinical trials are in a need of more efficient supply chain systems that can bring more transparency and risk mitigation strategies. Currently the clinical …
Clinical development programmes for orphan drugs present considerable financial and logistical challenges for pharmaceutical sponsors. Within this article we will look into some Logistical Challenges …
Ann-Marie Huss of Multipharma Clinical Supplies Ltd submit a white paper on Analysing Trends in Global Comparator Sourcing and Distribution in 2015 and gives us …
Patient recruitment costs around 6-7% of the total and it is highest among all other cost components. Almost 80% of clinical trials are delayed due …
Community-acquired bacterial pneumonia is a common and important disease which is associated with significant morbidity and mortality worldwide. Various pathogens cause the disease, but often …
Dr. Sergiy Pakharyna, at Synergy Group Ukraine, Dr. Yuri Afonchikov of Synergy Research Group, analyses the marketing authorization and clinical trials regulations in Ukraine by …
Romania is located in Southeastern Central Europe, north of the Balkan Peninsula and on the western shore of the Black Sea. With a population of …
This article examines the current operational landscape of biosimilar clinical drug development and identifies opportunities to decrease the risks associated with increasing competition. With an …
It is widely recognised that putting the patient at the centre of a trial’s design can significantly improve the quality and accessibility of data collection. …
Stroke, as it has recently been redefined, is any objective evidence of permanent brain, spinal, or retinal cell death due to a vascular cause. In …
Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.
